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Abstract
Background: Xylitol has antiadhesive effects on Streptococcus pneumoniae and inhibits its growth,
and has also been found to be effective in preventing acute otitis media and has been used in
intensive care as a valuable source of energy.
Results: We evaluated the oxidative burst of neutrophils in rats fed with and without xylitol. The
mean increase in the percentage of activated neutrophils from the baseline was higher in the xylitol-
exposed group than in the control group (58.1% vs 51.4%, P = 0.03 for the difference) and the mean
induced increase in the median strength of the burst per neutrophil was similarly higher in the
xylitol group (159.6 vs 140.3, P = 0.04). In two pneumococcal sepsis experiments rats were fed
either a basal powder diet (control group) or the same diet supplemented with 10% or 20% xylitol
and infected with an intraperitoneal inoculation of S. pneumoniae after two weeks. The mean
survival time was 48 hours in the xylitol groups and 34 hours in the control groups (P < 0.001 in
log rank test).
Conclusion: Xylitol has beneficial effects on both the oxidative killing of bacteria in neutrophilic
leucocytes and on the survival of rats with experimental pneumococcal sepsis.
Background
Xylitol is a five-carbon polyol sugar widely distributed in
plants, e.g. plums, strawberries and raspberries [1]. In
humans, it is metabolised in the liver to glucose, glycogen
and lactic acid. It affects blood glucose levels less than
does glucose [2], and it has been used as a component in
parenteral nutrition [3,4]. Xylitol has anticatabolic and
antiketogenic effects and improves nitrogen balance in
rats during septic infection [5,6]. This anabolic effect is
thought to be the cause of the improved survival seen after
thermal injury [7,8] and sepsis of intestinal origin [5].
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Xylitol is an unsuitable source of energy for many micro-
organisms, and it inhibits the growth of Streptococcus pneu-
moniae [9] and some other bacteria even in the presence of
glucose, but not in the presence of fructose [10-12]. It has
antiadhesive effects on both S. pneumoniae and Haemo-
philus influenzae [13] which are mediated by its effect on
the cell wall of the bacteria [14]. Xylitol reduces the inci-
dence of dental caries when given orally in chewing gum
on a regular basis [15], and it has been found to be effec-
tive in preventing acute otitis media by up to 42% when
administered either in chewing gum or as a syrup [16,17].
It causes a marked reduction in the intracellular redox
state due to the rapid production of NADH and NADPH
in the polyol dehydrogenase reaction [18], which may
improve the oxidative burst and bacterial killing in poly-
morphonuclear leucocytes.
To explore the mechanisms of action of xylitol further, we
measured the neutrophil respiratory burst related to bac-
terial oxidative killing in rats fed with or without xylitol.
Having hypothesised that xylitol may be beneficial in
modulating pneumococcal sepsis, we also evaluated the
effect of xylitol-supplemented enteral nutrition on the
course of pneumococcal sepsis in two rat experiments.
Methods
Animals and their nutrition
Six-week old male Sprague-Dawley rats were used
throughout. They were fed a basal powder diet, RM1 (Spe-
cial Diet Services, Witham, Essex, Great Britain), one kilo-
gramme of which contains 885 g cereal products (wheat,
barley and wheat feed), 60 g vegetable proteins, 25 g ani-
mal proteins (whey powder), 5 g soya oil, 7.1 g calcium,
2.9 g phosphorus, and 15 μg cholecalciferol. A list of the
other minor components of the diet is given in the manu-
facturer's brochure. The rats in the xylitol groups were fed
the same diet supplemented with 10% or 20% xylitol (w/
w) (Xyrofin Co., Kotka, Finland) for two weeks before
sampling in the burst trial and for two weeks before the
bacterial challenge and during the induced disease in the
survival experiments. The rats were kept in separate cages
in a temperature and light-controlled room (21–23°C,
12-hour light-dark cycle) and had free access to tap water.
The protocols were approved by the Ethical Committee
on Animal Experiments of the University of Oulu.
Respiratory burst test
The respiratory burst that reflects bacterial oxidative kill-
ing was measured using a commercial test (Bursttest,
Orpegen Pharma, Heidelberg, Germany) according to the
manufacturer's instructions. The test is based on the prin-
ciple that reactive oxygen mediates the transformation of
dihydrorhodamine 123 to rhodamine 123, which can be
detected by flow cytometry. Both the percentage of neu-
trophils with respiratory burst activity and the average
strength of the activity per neutrophil were analysed. The
respiratory burst was induced by E. coli in a standardized
manner. The baseline activity was measured in a tube con-
taining only buffer without bacteria and subtracted from
the induced response in each sample. A human blood
sample was tested with the rat samples in each series to
confirm the performance of the test. The results were ana-
lyzed by FACScan flow cytometry (Becton-Dickinson)
using the FACScan program.
Fifty animals were assigned to two groups of 25 to receive
either a control diet or the same diet supplemented with
10% xylitol for one week and 20% xylitol for the second
week (Figure 1). After two weeks a blood sample of 5 ml
was taken from the heart under Hypnorm-Dormicum
anaesthesia just before the rats were killed with an over-
dose of carbon dioxide and severing of the head. The res-
piratory burst test was performed as described above.
Survival experiments
In the first survival experiment sixty rats were assigned to
three groups of 20 each, receiving either a basal powder
diet or the same diet supplemented with 10% or 20% xyl-
itol (Figure 1). The mean weight of the animals was 171 g
(range 127 – 266) before the diet and 214 g (157 – 280)
at the time of the inoculation. The mean weight gain
resulting from the experimental diet was greater in the
control animals (55.7 g, p < 0.01) than in those receiving
10% xylitol (30.4 g) or 20% xylitol (35.4 g), but the mean
weights of the animals before inoculation did not differ
significantly between the groups.
In the second experiment forty rats were assigned to two
groups of 20, receiving either a control diet or the same
diet supplemented with 20% xylitol (Figure 1).
Bacterial strains and culture conditions
The rats were infected with S. pneumoniae type 3 (patient
isolate, National Public Health Institute strain collection,
Oulu, Finland), which had been stored at -80°C in
skimmed milk. After overnight incubation on a blood
agar plate in an atmosphere containing 5% CO2 at +37°C,
several colonies were inoculated into Brain Heart Infusion
medium (Difco Laboratories, Detroit, MI, USA) and again
incubated overnight at +37°C. The bacteria were then col-
lected by centrifugation for 15 min at 1500 × g and the
precipitate suspended in phosphate buffer, pH 7.2, until
the desired density was obtained with the McFarland den-
sity standards. The final bacterial concentration was con-
firmed by a standard plate dilution method on a blood
agar plate.
Bacterial challenge and samples
After two weeks on the experimental diet, the animals
were infected by intraperitoneal inoculation with 100 μlBMC Microbiology 2008, 8:45 http://www.biomedcentral.com/1471-2180/8/45
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of the bacterial suspension containing 2 × 106 colony-
forming units (CFU)/ml (first experiment) or 2 × 107
CFU/ml (second experiment). Blood samples were taken
by suborbital puncture 12, 36 and 60 hours post-inocula-
tion. A sample of 50 μl was diluted immediately with 50
μl of sterile 0.9% NaCl and spread on a gentamycin blood
agar plate. The number of pneumococcal colonies was
counted after overnight incubation at + 37°C and classi-
fied as 1) negative, 2) positive with less than 102 CFU/ml,
3) positive with 102 to 103 CFU/ml, or 4) positive with
more than 103 CFU/ml.
Serum concentrations of xylitol were measured in blood
samples taken 12 hours after the challenge. The samples
were kept at room temperature for 5 hours and centri-
fuged at 1500 × g for 15 min, after which the serum was
collected. The concentration of xylitol in each sample was
measured by enzymatic assay using the polyol dehydroge-
nase-based procedure of Boehringer Mannheim (Man-
nheim, Germany). Because of the small amounts of serum
available, some measurements were performed by pool-
ing 4–5 samples within each diet group (Table 1). The
detection limit of the assay was 0.07 mmol/L (10 μg/mL).
The animals were monitored visually at intervals of about
2–4 hours and the experimental diet was continued
throughout the trial. The spleens of the deceased rats were
cultured to ensure that death had been caused by pneu-
mococcal sepsis. Pneumococci in the blood and spleen
cultures were identified by their typical colony morphol-
ogy and optochin sensitivity.
Statistical analyses
The sample size for the burst test trial was estimated by
assuming that the mean difference in the percentage of
neutrophils in which the respiratory burst occur between
The protocol of the burst test and first and second survival experiments, showing the diet groups, inoculation protocol and fol- low-up of the animals Figure 1
The protocol of the burst test and first and second survival experiments, showing the diet groups, inoculation 
protocol and follow-up of the animals.BMC Microbiology 2008, 8:45 http://www.biomedcentral.com/1471-2180/8/45
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the xylitol and control group would be 2.5%. With a
power of 80% and an alpha error of 0.05 a sample size of
21 rats per group was needed. Since some of the tests
might fail, it was decided that the final size of both groups
should be 25 rats. Mean differences with 95% confidence
intervals were calculated for continuous variables in the
xylitol and control groups and the statistical significances
were tested with Students' t-test. The significance in the
differences of proportions between the groups was tested
with the SND (standard normal deviation) test. The mean
and median survival times with 95% confidence intervals
(CI) were calculated, and the survival times of the groups
were calculated by the Kaplan-Meier method, the differ-
ences being tested with the Log Rank test.
Results
Respiratory burst
The mean increase from the baseline in the percentage of
activated neutrophils was 58.1% in the xylitol group (n =
21) and 51.4% in the control group (n = 23) (mean differ-
ence 6.7%, CI 0.7–12.8, P = 0.03 for the difference) (Fig-
ure 2A). Correspondingly, the mean induced increase in
the median value of the strength of the burst at the cell
level was 159.6 in the xylitol group and 140.3 in the con-
trol group (mean difference 19.3, CI 0.7–37.9, P = 0.04 for
the difference) (Figure 2B). The results of six samples were
not available due to missed incubation time.
Survival experiments
Blood and spleen cultures
All the animals with positive blood cultures that died dur-
ing the follow-up also had highly positive spleen cultures
for pneumococci post mortem. Six animals that remained
apparently healthy during the follow-up were killed 109
hours after the challenge. Blood and spleen cultures were
negative except that for a few pneumococcal colonies
growing in the blood culture of one animal and one col-
ony in the spleen culture of another, both in the xylitol
group. When the results of both experiments were com-
bined, the blood cultures 12 hours after inoculation were
significantly more often negative in the 20% xylitol
groups than in the control group (17.5% vs 2.5%, P =
0.03).
All the blood and spleen cultures from the animals that
died from obvious clinical sepsis showed the growth of
abundant, slimy colonies typical of type 3 S. pneumoniae.
Five randomly chosen colonies were serotyped and iden-
tified as type 3. By contrast, the colonies isolated from the
blood or spleen of the animals in the xylitol group with-
out clinical signs of sepsis were small and dry and could
not be serotyped.
Table 1: Serum samples, numbers of animals in pools and xylitol 
concentrations in 20 rats fed a diet with 20% xylitol 
supplementation.
Sample Total no. of animals Xylitol concentration (mmol/L)
1 – 4 10 < 0.07
51 0 . 0 7
63 0 . 0 7
76 0 . 1 3
Increase in the percentage of activated neutrophils from the baseline (A) and increase in the median value for the strength of  the burst (B) when induced with E. coli in rats fed with and without xylitol Figure 2
Increase in the percentage of activated neutrophils from the baseline (A) and increase in the median value for 
the strength of the burst (B) when induced with E. coli in rats fed with and without xylitol. The lines indicate mean 
values.BMC Microbiology 2008, 8:45 http://www.biomedcentral.com/1471-2180/8/45
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Survival time
In both experiments the animals with sepsis in the xylitol
groups survived longer than those in the control groups,
the mean survival times being 34 hours (CI 30 to 38,
median 32 hours) in the control groups and 46 hours (40
to 51, median 36 hours) in the xylitol groups. In experi-
ment 1 the mean survival time was 33 hours in the control
group (CI 31 to 36, median 32 hours), 44 hours in the
10% Xylitol group (CI 37 to 51, median 38) and 45 hours
in the 20% Xylitol group (CI 40 to 50, median 41, P value
in log rank test 0.0004, Figure 3). In experiment 2 the
mean survival time was 34 hours in the control group (CI
26 to 41, median 28 hours) and 47 hours in the 20% Xyl-
itol group (CI 34 to 61, median 32, P value in log rank test
0.01.
Concentration of xylitol in serum
No detectable amount of xylitol was found in the serum
of any of the animals in the control group or the 10% xyl-
itol group, whereas a concentration of 1.3 mmol/L was
present in one pooled sample from the 20% xylitol group
and a level just above the detection limit was seen in two
other samples (Table 1).
Survival of the animals after intraperitoneal inoculation with S. pneumoniae, by diet group in experiments 1 and 2 Figure 3
Survival of the animals after intraperitoneal inoculation with S. pneumoniae, by diet group in experiments 1 
and 2.BMC Microbiology 2008, 8:45 http://www.biomedcentral.com/1471-2180/8/45
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Discussion
We were able to show that dietary xylitol enhanced oxida-
tive killing in neutrophilic leucocytes and prolonged the
survival of rats suffering from sepsis caused by S. pneumo-
niae type 3. These findings are in accordance with a previ-
ous report which showed that parenteral xylitol improved
the survival of rats suffering from intestinal sepsis [5]. This
better survival in the presence of sepsis probably entails
several contributory factors. Xylitol has effects on the
growth [9], expression of capsular polysaccharides [14]
and adhesion [13] of S. pneumoniae. It has also been
shown to have several beneficial metabolic effects in ani-
mals suffering from trauma or sepsis [5-8], and the
enhanced functioning of neutrophilic leucocytes found in
the present study provides an extension to this list.
The initiation of the respiratory burst in polymorphonu-
clear neutrophils requires NAPDH. Xylitol may affect the
metabolism of neutrophils in two ways: firstly by improv-
ing the glycaemic control under the hyperglycaemic stress
reaction during sepsis, or secondly by causing a marked
reduction in the intracellular redox state due to the rapid
production of NADH and NADPH in the polyol dehydro-
genase reaction [18]. By thus affecting the energy metabo-
lism of the leukocytes, it may interfere with their
functioning, and thus modulate the course of the invasive
bacterial disease. Xylitol has also been shown to be cyto-
protective during oxidative stress [19].
S. pneumoniae is one of the most common bacteria causing
invasive infections in otherwise healthy persons. The max-
imal expression of capsular polysaccharides is known to
be essential for its systemic virulence, however, because of
the antiphagocytic properties of the capsule [20]. We have
shown earlier that the ultrastructure of the pneumococcal
capsule becomes ragged after exposure to xylitol [14].
Interestingly, two pneumococcal isolates from xylitol-fed
rats with no clinical signs of septicaemia in the present
study grew rough colonies and were impossible to sero-
type, suggesting that the virulent type 3 pneumococci had
become avirulent, not expressing the genes needed for
capsular synthesis. The regM  gene, encoding catabolite
control protein, has recently been identified in pneumo-
coccus [21]. This gene is involved in the catabolism of car-
bohydrates, and its mutation resulted in a significant
reduction in the transcription of the locus of capsular
polysaccharide biosynthesis. Further studies would be
needed, however, to show, whether a xylitol diet can lead
to repression of the regM gene and consequently to
reduced capsular synthesis.
The serum concentrations of xylitol recorded here were
low, as was to be expected, because xylitol is absorbed
slowly from the gut by free diffusion, the rate of absorp-
tion being 1/5 of that of glucose [22]. Xylitol is able to
inhibit the growth of pneumococci significantly at a con-
centration of 65 mmol/L (1%) [9], and concentrations of
the same magnitude are expected for the morphological
changes [14]. The highest serum concentration recorded
in this experiment was 1.3 mmol/L, in the 20% xylitol
group, we did not measure intra-tissue or intracellular
concentrations, nor do we know whether or not the serum
concentrations reflect the amount of xylitol present dur-
ing the critical steps in the infection process.
Ardawi5 found that xylitol enhances survival in sepsis of
intestinal origin, where the growth or virulence of the aeti-
ological microbes is not known to be susceptible to xyli-
tol. Parenteral xylitol has been shown to have a nitrogen-
sparing effect during sepsis and after burns in rats [5,6],
and Ardawi [5] suggested that this may be the mechanism
for improved survival in the presence of sepsis. The nitro-
gen balance may nevertheless be only an indirect sign of a
better state, reflecting less serious inflammation, and not
the reason for the improvement in survival.
Oral xylitol is well tolerated in adults and children, the
only side-effect found being osmotic diarrhoea [22].
Parenteral xylitol can cause minimal hyperuricaemia, but
without any pathophysiological consequences [3]. Xylitol
has been used as a component of parenteral nutrition,
instead of or in addition to glucose, e.g. in patients with
diabetes [3,4]. Though tolerated well in modest doses,
large doses of xylitol administered intravenously have
been reported to cause renocerebral oxalosis with renal
failure [23,24]. These case reports of serious side-effects
raise a need for caution in the use of parenteral xylitol.
The factors influencing the severity of invasive bacterial
infections are quite well known, but only a few methods
of treatment aimed at slowing them down are in clinical
use. Xylitol, as a modulator of the functioning of leuko-
cytes during the inflammatory process, may open up new
possibilities for improving the prognosis for pneumococ-
cal sepsis.
Conclusion
Xylitol has beneficial effects on both the oxidative killing
of bacteria in neutrophilic leucocytes and on the survival
of rats with experimental pneumococcal sepsis.
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